RRAAPPIIDD IINNTTEEGGRRAATTIIOONN

CCOOUURRSSEE

for the

New to Oncology PAs & NPs

March 10, 2018

MMOOFFFFIITTTT CCAANNCCEERR CCEENNTTEERR HH.. LLeeee MMooffffiitttt CCaanncceerr CCeenntteerr && RReesseeaarrcchh IInnssttiittuuttee

VViinncceenntt AA.. SSttaabbiillee RReesseeaarrcchh BBuuiillddiinngg 1122990022 MMaaggnnoolliiaa DDrr..

TTaammppaa,, FFlloorriiddaa 3333661122

7:00 - 7:30am BREAKFAST/EXHIBITS

7:30 - 8:00am Welcome

Basic Principles of Cancer Management

Winston Tan, MD, FACP Mayo Clinic Florida

8:00 - 8:45am Clinical Pearls for the

New Advanced Provider Jessica McMillan, DNP, FNP, ARNP-BC Mayo Clinic Florida

8:45 - 9:15am Pharmacology I

Mechanism and Targets in Medical Oncology

Lindsay Williamson, ARNP, MSN, AOCNP Florida Cancer Specialists

9:15 - 9:45am Radiation Core Knowledge/

Complications Katherine Tzou, MD Mayo Clinic Florida

9:45 - 10:30am BREAK/EXHIBITS

10:30 - 11:00am Surgical Approach to Cancer Care Amit Merchea, MD Mayo Clinic Florida

11:00 - 11:45am Basics of Billing and Coding Melisa Chandler Florida Cancer Specialists

11:45 - 12:30pm Hematologic Malignancies: Approach

to Understanding Pathogenesis and Treatment

Chakra Chaulagain, MD Cleveland Clinic Florida

12:30 - 1:00pm LUNCH/EXHIBITS

1:00 - 1:30pm How do we best learn? Winston Tan, MD, FACP Mayo Clinic Florida

1:30 - 2:00pm Oncologic Emergencies & Symptom

Management Terry Gruchow, PA-C Moffitt Cancer Center

2:00 - 2:30pm Clinical Trials Cheryl Habaue, RN, MSN, CCRP Memorial Healthcare System

2:30 – 3:00pm Pathology and How to Understand It Shahla Masood, MD University of Florida, Jacksonville

3:00—3:30pm Lessons Learned Winston Tan, MD, FACP Mayo Clinic Florida

2018 2018 FLASCO Rapid Integration CourseFLASCO Rapid Integration Course Moffitt Cancer Center, Vincent Stabile Research BuildingMarch 10, 2018

Florida Society of Clinical Oncology Welcomes You

Rapid Integration Training The mission of the Rapid Integration Course is to offer a course that is relevant,

practical and patient centered that could be used as a durable and long term project that will positively impact the speed in which entry level oncology physician assistants and

nurse practitioners integrate into the oncology practice setting.

Chairman

Winston Tan, MD, FACP Associate Professor of Medicine Vice Chair Hematology/Oncology for Education Program Director Hematology/Oncology Fellowship Chair Cancer Survivorship Program Mayo Clinic Florida

BIOGRAPHY: Dr. Winston Tan is focused on translating basic science principles into tangible treatment options for patients with cancer. He is interested in the development of novel targets of therapy including immunotherapy that would lead to less toxic treatments for cancer. These treatments would also be able to lead to meaningful improvement of quality of life, prolongation of the time to cancer progression and hopefully improved survival. Dr. Tan’s professional highlights are his leadership roles as Vice Chair of Hematology/Oncology Mayo Clinic Florida for Education, Associate Chair for Faculty Faulty Development, Department of Medicine, Mayo Clinic Florida, Fellowship Program Director Hematology/Oncology, Mayo Clinic Florida, Board Member, Chair of the Membership Committee, and member of Program Committee in the Florida Society of Clinical Oncology. He is a Fellow of the American College of Physicians, and Member Survivorship Committee of the American Society of Clinical Oncology. Dr. Tan is a passionate, empowering and focused cancer educator.

Vice Chairman

Terry Gruchow, PA-C, MHS Moffitt Cancer Center BIOGRAPHY: Terry Gruchow joined Moffitt Cancer Center as an Advanced Practice Professional with Department of Internal and Hospital Medicine in 2006. A graduate of the University of Wisconsin and Lock Haven University (Pa), his clinical

responsibilities include the Moffitt Direct Referral Center (the Center’s Urgent Care clinic) and the Inpatient Wards. His other responsibilities include Administrator of the Moffitt PA Student Mentoring Program and the Moffitt Student Shadowing Program. He is Adjunct Faculty at Barry University and South University. A member of The American Academy of Physician Assistants, Association of Physician Assistants in Oncology and Society of Hospital Medicine, he is the West Central Region Director for the Florida Academy of Physician Assistants. Terry is also on the Moffitt APP Council, serves as the PA Liaison to the FLASCO Board of Directors and is a member of the South University PA Program Advisory Board.

RAPID INTEGRATION COURSE

PROGRAM PLANNING TEAM

Winston Tan, MD, FACP

Mayo Clinic Florida Chairman

Terry Gruchow, PA-C, MHS Moffitt Cancer Center

Vice-Chairman

Seth Berkowitz, LCSW, CCLS

The Leukemia & Lymphoma Society

Chakra Chaulagain, MD, FACP Cleveland Clinic Florida

Ana Rosa Espinosa, DNP, MBA, RN, OCN

Memorial Cancer Institute

Terry Gruchow, PA-C, MHS Moffitt Cancer Center

Jessica McMillan DNP, FNP, ARNP-BC

Mayo Clinic Florida

BASIC PRINCIPLES OF CANCER MANAGEMENT 7:30 am – 8:00 am

Objectives:

1. Define the purposes of cancer therapy 2. Describe the differences among chemotherapy, hormonal therapy, immunotherapy and

kinase inhibitors 3. Have a basic understanding of the different drug classifications of chemotherapy, the different

types of hormonal therapy and the many targets that therapies affect 4. Have a basic understanding for common toxicities for cancer treatments 5. Define available resources for drug indications, dosing and adverse effects profile

Winston Tan, MD, FACP Associate Professor of Medicine Vice Chair Hematology/Oncology for Education Program Director Hematology/Oncology Fellowship Chair Cancer Survivorship Program Mayo Clinic Florida

CLINICAL PEARLS FOR THE NEW ADVANCED PRACTICIONER 8:00 am – 8:45 am

Objectives: 1. Review the biology and pathology of neoplastic diseases 2. Discuss cancer therapies 3. Correlate review of systems and implications to physical examination 4. Review potential side effects/toxicities of treatment therapies and effects

Jessica McMillan, DNP, FNP, ARNP-BC Mayo Clinic Florida BIOGRAPHY: Dr. Jessica McMillan is an Advanced Registered Nurse Practitioner at Mayo Clinic Florida in the Division of Hematology/Oncology. She has over 19 years of experience as a leader, educator and patient care advocate. She also works for Brooks

Rehabilitation Hospital caring for patients multiple disabilities incurred by motor vehicle accidents, traumatic brain injuries, spinal cord injuries, and an array of other debilitating illnesses that require rehabilitation and care. In addition to working as a NP at Mayo Clinic and Brooks Rehabilitation Hospital, she continues to teach for University of North Florida, empowering new graduate nurses to provide patients with care, compassion and expert care always putting the needs of the patient first. She obtained her Nurse Practitioner Certificate at University of North Florida and is expecting to graduate with her Doctorate of Nursing Practice, with a sub-specialty of Palliative Care on July 24, 2015. She transitioned from caring to patients in the Intensive Care Unit to Oncology 8 years ago because she wanted to develop relationships with her patients and have a positive impact on their lives as they dealt with life limiting illness in the oncologic setting.

PHARMACOLOGY 101 MECHANISM AND TARGETS IN MEDICAL ONCOLOGY

8:45 am – 9:15 am

Objectives: 1. Define the purposes of cancer therapy 2. Describe the differences among current cancer treatments 3. Have a basic understanding of the different drug classifications of chemotherapy, the

different types of hormonal therapy and the many targets that therapies affect. 4. Have a basic understanding for common toxicities for cancer treatments 5. Define available resources for drug indications, dosing and adverse effects profile

Lindsay Williamson, ARNP, MSN, AOCNP Florida Cancer Specialists BIOGRAPHY: Lindsay Williamson is board certified as an Advanced Oncology Certified Nurse Practitioner as well as an Adult Nurse Practitioner. She received her BSN at West Chester University in West Chester, Pennsylvania and her MSN at La Salle University in Philadelphia, Pennsylvania. Lindsay has been an Oncology Nurse for 17

years with 9 of those years in the role of Nurse Practitioner. She has worked in a variety of settings including inpatient and outpatient as well as community based and academic based. Also, she has worked in a variety of roles including Oncology Staff Nurse, Infusion Nurse, and ARNP in an academic setting and community practice, Pharmaceutical Sales Representative and Clinical Operations Manager of the Lab Draw and Infusion areas at Moffitt Cancer Center. Lindsay is a member of the Advanced Practice Society for Hematology and Oncology and the Oncology Nursing Society.

RADIATION CORE KNOWLEDGE/COMPLICATIONS

9:15 am – 9:45 am Objectives:

1. Discuss the definition of radiation therapy. 2. Describe the indications for radiation treatment. 3. Discuss potential side effects. 4. Walk through the process patients go through for treatment.

Kathrine Tzou, MD Mayo Clinic Florida BIOGRAPHY: Dr. Katherine Tzou is an Assistant Professor of Radiation Oncology at Mayo Clinic Florida. She specializes in radiation therapy for genitourinary cancers, gynecologic cancers, breast cancer, and skin cancer. Dr. Tzou completed her Radiation Oncology Residency in 2012, at the Mayo Clinic College of Medicine. In 2008, Dr. Tzou completed her Preliminary Internal Medicine Year at Fletcher Allen Health Care,

University of Vermont. Dr. Tzou attended medical school at The Ohio State University College of Medicine. She serves as a panel member of the National Comprehensive Cancer Network Testicular Cancer Guidelines Committee, chair of the Mayo Clinic Florida Radiation Oncology Research Executive Committee, Co-chair of the Mayo Clinic Genitourinary Disease Site Group, member of the American Society for Radiation Oncology (ASTRO) Membership Committee, and associate residency direction for Radiation Oncology at Mayo Clinic Florida.

SURGICAL APPROACH TO CANCER CARE 10:30 am – 11:00 am

Amit Merchea, MD Mayo Clinic Florida

BIOGRAPHY: Dr. Amit Merchea accomplished his clinical fellowship, as well as his General Surgery Residency at Mayo School of Graduate Medical Education, Mayo Clinic College. In 2007, Dr. Merchea completed his medical degree at Saint Louis University School of Medicine. He is board certified in colon and rectal surgery, as well as general surgery by the American Board of Surgery. Dr. Merchea treats colon cancer, Crohn’s disease, rectal cancer, and ulcerative colitis. Dr. Merchea is interested in the research of colon and rectal cancer, ulcerative

colitis, Crohn’s disease, benign diseases of the colon and rectum, diverticular disease, and presacral tumors.

PATHOLOGY AND HOW TO UNDERSTAND IT 11:00 am – 11:45 am

Objectives: 1. To familiarize the participant with pathology as a discipline of medicine. 2. To highlight the role of pathologists in understanding the fundamental concepts of human

diseases. 3. To demonstrate the contributions of pathologists in cancer care and oncology practice.

Shahla Masood, MD Professor and Chair, Department of Pathology University of Florida College of Medicine – Jacksonville Medical Director, UF Health Breast Center Chief of Pathology and Laboratory Medicine, UF Health Jacksonville

BIOGRAPHY: Dr. Shahla Masood is a Persian born physician, who currently holds the positions of Professor and Chair of the Department of Pathology at University of Florida College

of Medicine – Jacksonville and Chief of Pathology and Laboratory Medicine at UF Health Jacksonville. She is also the Director of the Cytopathology and Breast Pathology Fellowship Training Program. In addition, Dr. Masood is the Medical Director of UF Health Breast Center. An internationally recognized expert in breast cancer diagnosis and prognosis, Dr. Masood has fostered the concept of an integrated multidisciplinary approach in breast cancer care, research, and education. She is the founder and Editor-in-Chief of The Breast Journal, the founder and past president of the “International Society of Breast Pathology,” the Director of the “Annual Multidisciplinary Symposium on Breast Disease”, and “The Breast Cancer Public Forum”. Dr. Masood is heavily involved in the study of minimally invasive procedures such as fine needle aspiration biopsy and ductal lavage in providing diagnostic and prognostic information in high risk and breast cancer patients. She defined the cytomorphology of high-risk proliferative breast disease in the early 1990s and has pioneered the concept of cytomorphology as a breast cancer predictor.

Dr. Masood is the author of several textbooks, book chapters, and numerous publications. She is a frequent speaker at national and international symposiums and consensus meetings. She is also a member of the board of trustees of several prestigious scientific societies and organizations at local, regional, national and international levels.

Dr. Masood has received numerous awards and recognition for her scientific work, her contribution to advancing global breast health education and her efforts to improve the quality of breast health care. She is the recipient of “The 2010 Breast Health Global Initiative Award,” “Courage to Teach Award” from National Accreditation Council for Graduate Medical Education, and Florida Times Union “Eve Award,” to name a few. She has been named as one of the Top Doctors in America, Top Doctors in Cancer and one of the 20 Top Most Influential Professors in Oncology at an international level. In 2015, Dr. Masood was honored in Rome, Italy by Susan G. Komen Italia, a partnership between Susan. G. Komen and the Catholic University in Rome for her widespread contributions to breast cancer advocacy, and initiation of the Italian “Race for the Cure” in 2000. Dr. Masood is a patient advocate, a partner in community affairs and an accomplished artist and gourmet chef. She is the mother of two accomplished physicians, Dr. Ali Kasraeian, urologist, and Dr. Sina Kasraeian, orthopedic surgeon.

HEMATOLOGIC MALIGNANCIES: APROACH TO UNDERSTANDING PATHOGENESIS AND TREATMENT

11:45 am – 12:30 pm Objectives:

1. To familiarize with malignant hematology pharmacology. 2. To learn common indications and usage of malignant hematology anticancer drugs. 3. To understand side effects of malignant hematology anticancer drugs.

Chakra Chaulagain, MD, FACP Cleveland Clinic Florida BIOGRAPHY: Dr. Chakra Chaulagain completed clinical and research fellowship in Hematology and Oncology at Tufts University, New England Medical Center in Boston, MA with emphasis in malignant hematology/bone marrow transplant. He completed

Internal Medicine residency at John H. Stroger Jr. Hospital of Cook County/Rush University in Chicago, IL. Dr. Chaulagain attended medical school at Tribhuvan University institute of Medicine in Kathmandu, Nepal. Dr. Chaulagain is board certified in Internal Medicine, Medical Oncology, and Hematology. He is extensively published and researched in the area of malignant hematology and plasma cell diseases. His areas of expertise include multiple myeloma and AL amyloidosis.

Dr. Chaulagain is a member of the Florida Society of Clinical Oncology, serving on the Board of Directors and the Membership and Program Committees. He is also the fellow of American College of Physicians and member of ASH and ASCO. He has been working as a staff physician in Cleveland clinic since 2014.

HOW DO WE BEST LEARN? 1:00 pm – 1:30 pm

Objectives: 1. Discuss and review the principles of learning 2. Define the basis of learning that is best for individuals 3. Empower learners to be teachers in their practices

Winston Tan, MD, FACP Associate Professor of Medicine Vice Chair Hematology/Oncology for Education Program Director Hematology/Oncology Fellowship Chair Cancer Survivorship Program Mayo Clinic Florida

ONCOLOGIC EMERGENCIES & SYMPTOM MANAGEMENT 1:30 pm – 2:00 pm

Objectives: 1. To identify and recognize Oncologic Emergencies in cancer patients 2. To learn and know how to implement effective treatment options 3. To identify and recognize Oncologic Urgencies with implementation of treatment regimens

Terry Gruchow, PA-C, MHS Moffitt Cancer Center

CLINICAL TRIALS 2:00 pm – 2:30 pm

Objectives: 1. Discuss the definition of clinical trials 2. Describe the types, regulations, design, and randomization of clinical trials 3. Discuss data management and analysis of clinical trials

Cheryl Habaue, RN, MSN, CCRP Memorial Healthcare Systems

BIOGRAPHY: Cheryl Habaue is the Manager of Pediatric and Adult Oncology Research at Memorial Healthcare System in Hollywood, FL. She received her BSN from Mount Mercy College in Cedar Rapids, Iowa and MSN from Chamberlain College of Nursing. She has been in research for the past 5 years working on studies related to all cancers including but not limited to Lung, Breast, GI, GYN, GBM, Leukemia, Multiple

Myeloma, Lymphoma, Head and Neck, as well as Sarcomas and Melanomas.

BASICS OF BILLING AND CODING 2:30 pm – 3:00 pm

Objectives: 1. Discuss basics of coding and billing 2. Describe the CCI/MUE initiative 3. Outline the Compendia and Journals of off-label coverage

Melisa Chandler Director of Revenue Cycle, Corporate Office Florida Cancer Specialists

BIOGRAPHY: As Director of Revenue Cycle, Melisa Chandler is responsible for providing leadership and direction to the Florida Cancer Specialists’ business office. In this role, she supports FCS through accurate billing, timely collections, and precise payment posting, while delivering a positive patient experience. Since joining FCS in

2010, she has held several finance-related positions of increasing responsibility. Originally from Anderson, Indiana, Melisa has 17+ years of management experience, 12 years in the medical field and is Six Sigma Green Belt certified.

LESSONS LEARNED

3:00 pm – 3:30 pm

Objectives: 1. Elaborate and summarize topics learned 2. Describe and illustrate how topics learned can be used 3. Establish and prepare a framework for continuous learning for the learner

Winston Tan, MD, FACP Associate Professor of Medicine Vice Chair Hematology/Oncology for Education Program Director Hematology/Oncology Fellowship Chair Cancer Survivorship Program Mayo Clinic Florida

Rapid Integration Course

March 10, 2018 Moffitt Cancer Center Tampa, Florida

ROSTER OF ATTENDEES

(Current as of March 5, 2018)

Suzan Abduljawad MSN, PhDc University of South Florida Wesley Chapel, FL

Barbara Adamiak Florida Cancer Specialists Sarasota, FL

Nick Amendola Senior Key Account Specialist Amgen

Stephanie Andrews RN, MS, ANP-BC Moffitt Cancer Center Temple Terrace, Fl

Robert Armenia Astellas Pharma US Tampa, FL

Lily Basadre MSN, ARNP Clinical Nurse Consultant, South Region Celgene

Valerie Bastani Nurse Educator Merck

Seth Berkowitz LCSW, CCLS Senior Patient Access Manager The Leukemia & Lymphoma Society Hollywood, FL

Debbie Billingsley Celgene Valrico, FL

Taylor Blalock Eisai Oncology

Amanda Bridges Florida Society of Clinical Oncology

Linnie Burney Celgene

Melisa Chandler Director of Revenue Cycle Florida Cancer Specialists Ft. Myers, FL

Chakra Chaulagain MD, FACP Cleveland Clinic Weston, FL

Janette Chirino ARNP Moffitt Cancer Center Lakeland, FL

Sheila Covaleski RN Mayo Clinic Florida Ponte Vedra Beach, FL

Timothy Curlee Florida Region Sales Manager Teva Oncology Sarasota, FL

Chad Davidson AstraZeneca

Katrina Dever ARNP Florida Cancer Specialists Orlando, FL

Brian Donnelly Midatech Pharma

Ed Earnest Merck

Nini Eng RN Neurosurgery Moffitt Cancer Center Wesley Chapel, FL

Mary Kay Foody Exelixis

Scott Gingrich AstraZeneca

Crystal Glass Bayer

Lillian Gonzalez ARNP Moffitt Cancer Center Tampa, FL

Samantha Gooss ARNP Moffitt Cancer Center Brandon, FL

Terry Gruchow PA-C Moffitt Cancer Center Oldsmar, FL

Cheryl Habaue MSN, RN, CCRP Oncology Research Manager Memorial Healthcare System Hollywood, FL

Julie Hemphill ARNP Florida Cancer Specialists Orlando, FL

Yvette Herrington ARNP Pinellas Hematology & Oncology Brandon, FL

Aly Hirji Clovis Oncology

Donna Huffstater Merck Morristown, TN

Kirsten Ireson Eisai Oncology Madeira Beach, FL

Lara Jackson Novartis Oncology

Scott Jorgensen Incyte Corporation

Lisa Kaschak Astellas Pharma US

Christofer Kemp AbbVie Pharmaceuticals DeLand, FL

Julie King Territory Manager Clovis Oncology Melbourne, FL

Rapid Integration Course

March 10, 2018 Moffitt Cancer Center Tampa, Florida

ROSTER OF ATTENDEES

(Current as of March 5, 2018)

David Konicek Customer Team Leader Merck

Chris Kresl Pfizer Oncology

Katie LaPorta RN Moffitt Cancer Center Tampa, FL

Luke Lippitt AstraZeneca

Rhonda Loos Bayer

Shahla Masood MD Professor and Chair Department of Pathology and Laboratory Medicine Medical Director University of Florida Jacksonville, FL

Richard Massaro Teva Oncology Tampa, FL

Jill Matteis Pfizer Oncology

Rebecca McLamara Novartis Oncology

Jessica McMillan DNP, ARNP Mayo Clinic Florida Jacksonville, FL

Amit Merchea MD Assistant Professor of Surgery Mayo Clinic Florida Jacksonville, FL

Trenton Miller Midatech Pharma Mary Ann Milone ARNP-BC, AOCNP®, PhD Miami Beach, FL

Carla Moodie MS, PA-C

Thoracic Surgery Moffitt Cancer Center Riverview, FL

Rhory Moss Incyte Corporation

Cynthia Muller BSN, MJ Clinical Support Specialist Bayer Oncology Palm Harbor, FL

Ashley Naylor ARNP Moffitt Cancer Center Land o Lakes, FL

Carol Parrales ARNP Sylvester Cancer Center/University of Miami Plantation, FL

Katie Pell Amgen

Heather Peterson AbbVie Pharmaceuticals Dorothy Phillips Executive Director Florida Society of Clinical Oncology Riverview, FL

Brian Pipko Astellas Pharma US

Nancy Pitruzzello ARNP, DNP Mayo Clinic Florida Jacksonville, FL

Subrena Powell MSN Moffitt Cancer Center Tampa, FL

Kadly Ruder DNP© University of South Florida Apopka, FL

Lisa Syktich Teva Oncology Lake Mary, FL

Liz Taaffe

BriovaRx

Winston Tan MD Mayo Clinic Florida Jacksonville, FL

Lisa Tawil Sanofi-Genzyme

Mierlyn Tejada Moffitt Cancer Center Tampa, FL

Jeff Trudel Incyte Corporation

Katherine Tzou MD Assistant Professor of Radiation Oncology Mayo Clinic Florida Jacksonville, FL

Mark Ulrich Teva Oncology Bradenton, FL

Nina Wadhwa RN Clinical Research Infusion RN Moffitt Cancer Center Wesley Chapel, FL

Danielle Walker DNP, ARNP, AGNP-C Department of Breast Oncology Moffitt Cancer Center Plant City, FL

Jessica Wang ARNP

Katrina Williams Assistant Executive Director Florida Society of Clinical Oncology

Lindsay Williamson ARNP, MSN, AOCNP, ANP Florida Cancer Specialists Holiday, FL

Katie Zacher MBA Director Florida Hospital Medical Group Apopka, FL

10th ANNUAL GREAT STRIDES TOGETHER with RAPID INTEGRATION COURSE

21st Century Oncology Developments for the APP/RN Physician Teams

March 9 & 10, 2018

ACCREDITATION STATEMENTS

The Leukemia & Lymphoma Society

Approval for nurses has been obtained by the Southern Florida Chapter of The Leukemia & Lymphoma Society under provider number 50-12996 (Expiration Date: 10/31/2018) to award

up to 13.0 contact hours through the Florida Board of Nursing.

This document must be retained by the licensee for a period of four years after the course ends. Do not send to the Florida Board of Nursing.

The Florida Society of Clinical Oncology maintains responsibility for this program.

American Academy of Physician Assistants

This program has been reviewed and is approved for a maximum of 13.0 hours of AAPA

Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.

This program was planned in accordance with AAPA's CME Standards for Live

Programs and for Commercial Support of Live Programs.

10th ANNUAL GREAT STRIDES TOGETHER 21ST Century Oncology Developments for the APP/RN/Physician Teams

with Rapid Integration Course

FACULTY DISCLOSURES

Faculty participating in these programs are expected to disclose to the audience any real or apparent relationships with industry that may have a direct bearing on the subject matter of the program.

Seth Berkowitz, LCSW, CCLS No Relationships to Disclose

Florence Buenconsejo, ARNP, MSN, OCN No Relationships to Disclose

Melisa Chandler No Relationships to Disclose

Chakra Chaulagain, MD No Relationships to Disclose

Michael Diaz, MD Consultant for Janssen

Ana Rosa Espinosa, DNP, MBA, RN, OCN No Relationships to Disclose

Michael Fradley, MD Novartis Pharmaceuticals

Terry Gruchow, PA-C No Relationships to Disclose

Cheryl Habaue, MSN, RN, CCRP No Relationships to Disclose

Megan Indermaur, MD Speaker’s Bureau for AstraZeneca

David Johnson, PA-C Consultant and Speaker’s Bureau for Amgen

Jeanelle King, PA-C Speaker’s Bureau: Genentech

Jeffrey Lancet, MD Consultant for Astellas, BioSight, Celgene, R&D, and Jazz Pharmaceuticals

Elaine Macomb, ARNP No Relationships to Disclose

Shahla Masood, MD No Relationships to Disclose

Howard McLeod, MD No Relationships to Disclose

Jessica McMillan, DNP, FNP, ARNP-BC No Relationships to Disclose

Amit Merchea, Md No Relationships to Disclose

Wendy Migliore Sanchez, MSN, ARNP, AOCNP-BC No Relationships to Disclose

Kabir Mody, MD Consultant for Celgene Corp., Genentech, Merrimack Pharmaceuticals Grants/Research Support from Fibrogen Inc., Senwha Biosciences Inc., Tracon Pharmaceuticals, Genentech, AstraZeneca/Medimmune, Agios, and Arqule

Lisa Nodzon, PhD, ARNP, AOCNP Honorarium: BMS, Novartis, Genentech, Gilead Speaker’s Bureau: BMS, Novartis, Genentech, and Gilead

Cheryl Ryder, ARNP No Relationships to Disclose

Winston Tan, MD No Relationships to Disclose

Sara Tinsley, PhD, ARNP, AOCN Consultant: Amgen, Ariad, Celgene, Incyte, Jazz Pharmaceuticals, Novartis, Pfizer Speaker’s Bureau: Ariad, Celgene, Incyte, Jazz Pharmaceuticals, Novartis, and Takeda

Katherine Tzou, MD No Relationships to Disclose

Adrienne Vazquez, MSN, ACNP-BC, AOCNP No Relationships to Disclose

Kelsey Voit, MS, PA-C No Relationships to Disclose

Lindsay Williamson, ARNP, MSN, AOCNP No Relationships to Disclose

Musa Yilmaz, MD No Relationships to Disclose

Thank you for joining us for the

2018 Great Strides Together with Rapid Integration Course!

Download the FLASCO App!

Experience new ways to interact and find the information you need about FLASCO!

The FLASCO App Offers:

Access the Meeting Materials

View PowerPoint Presentations

Complete your Evaluations (Required for Continuing Education Credits)

Quick Access to the Attendee Roster

Search “FLASCO” in your app store to download the app onto your mobile device or scan this code with

your phone’s QR reader:

Be sure to visit www.FLASCO.org to learn more about upcoming events.

FLASCO Patient Portal is a “one-stop” resource for patients to access the important info they need regarding their cancer

treatment. Connect with FLASCO to stay up to date on the latest in oncology in Florida!

Find us on Facebook: https://www.facebook.com/ FloridaSocietyofClinicalOncology

LinkedIn:https://www.linkedin.com/company

/florida-society-of-clinical-oncology

Twitter: @FLASCO_ORG

FLASCO is proud

to announce the launch of

Patient Portal!

Visit our NEW portal! www.patients.flasco.org

The Florida Society of Clinical Oncology FLASCO was formed as a statewide 501(c)(3) nonprofit organization committed to facilitating and promoting multidisciplinary efforts to improve patient care in Florida. FLASCO continues to make strides in promoting excellence in care of patients afflicted with cancer and hematologic disorders and leads efforts to respond to policies and legislation that threaten to compromise patient access to quality cancer care. FLASCO is gaining momentum as more professionals use us as the catalyst to develop partnerships, share knowledge, and stand together to demonstrate strength and determination to move forward in the battle against cancer.

FLASCO consists of over 1,900 members that include physicians and their supporting staff, allied healthcare, and industry representatives that represent the oncology professionals of Florida. FLASCO will continue to be recognized as a nationally respected state professional society as we stand together as “the Voice of Oncology in Florida”.

Moffitt Cancer Center The Moffitt Medical Group (MMG) is Florida’s largest multi-disciplinary medical group practice that is dedicated to cancer care. The MMG, based at Moffitt Cancer Center, also provides services at other hospitals and clinics throughout the state of Florida and beyond. The MMG consists of 377 oncology specialists, including 221 board-certified physicians and 156 advanced practice professionals, as well as other staff who specialize in nearly 30 cancer programs and services. Our specialty-trained physicians are exclusively focused on cancer diagnosis, treatment and prevention. The MMG physician team includes cancer surgeons, medical oncologists, radiation oncologists, radiologists, pathologists and more, along with experts in cancer genomics and cardio-oncology.

Using a patient-centered, multi-specialty, team-based approach, MMG physicians blend clinical excellence with compassion to ensure that patients and their families feel connected to the team. MMG’s superior standing is underscored by the following distinctions:

• The development of clinical care Pathways, a unique approach to defining standards of cancer care, ensures that every patient receives the highest possible quality of care.

• MMG physicians participate in the National Comprehensive Care Network’s (NCCN’s) development of guidelines.

• Our National Cancer Institute (NCI) designation as a Comprehensive Cancer Center reflects the MMG commitment to clinical and academic excellence.

• MMG experts train the most promising future oncology physicians and advanced practice professionals.

• Many MMG physicians are leaders in their field who perform innovative, sometimes ground-breaking, research and clinical trials, which often exist exclusively at Moffitt Cancer Center; clinical trials provide unique opportunities for patients to receive the most advanced treatments with the potential to improve the national standard of cancer care.

The academic nature of the practice, coupled with the determination to treat every patient in accordance with the best available medical evidence, translates into superior quality and better outcomes, offering the best chance for beating cancer.

Thank YOU for Attending